The Patient Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.
Stay Connected. Manage Your Care.
Access your health information anytime and anywhere, at home or on the go, with MyHealth.
- Message your clinic
- View your lab results
- Schedule your next appointment
- Pay your bill
The MyHealth mobile app from Stanford Health Care puts all your health information at your fingertips and makes managing your health care simple and quick.
Guest Services
24/7
We are available to assist you
whenever you need it. Give us a call at
650-498-3333 or
PHYSICIAN HELPLINE
Have a question? We're here to help! Call 1-866-742-4811
Monday - Friday, 8 a.m. - 5 p.m.
REFER A PATIENT
Fax 650-320-9443
Track your patients' progress and communicate with Stanford providers conveniently and securely.
![](/was/20151211033644im_/https://stanfordhealthcare.org/content/dam/SHC/doctors-medicalstaff/l/li-gordon-md.jpg/_jcr_content/renditions/cq5dam.thumbnail.319.319.png.transform/221x221/q82/image.png)
Gordon Li, MD
Neurosurgeon
Practice Areas
Professional Education
- Board Certification: Neurosurgery, American Board of Neurological Surgery (2014)
- Medical Education: University of California Davis (2004) CA
- Residency: Stanford University (2011) CA
- Internship: Stanford University (2005) CA
- Bachelor of Science, Brown University, Neuroscience (1999)
Honors & Awards
- Plummer Linzy Scholarship, University of California, Davis (2000)
- Predoctoral Research Award, University of California, Davis (2001)
- Ernest Gold Award, University of California, Davis (2001)
- Junior AOA, University of California, Davis (2002)
- SANS Challenge Finalist, Congress of Neurological Surgeons (2008)
- Ruth L. Kirschstein National Research Service Award (PI), NIH-NCI (1F32CA132329-01) (2008-2010)
- Grand Opportunity Grant (co-investigator), NIH (RC2CA148491-01) (2009-2011)
- Center for Brain and Behavior Awards in Pediatric Neurosciences (co-investigator), Lucile Packard Children's Hospital (2009-2011)
- Disease Team Therapy Development Planning Award (Planning Investigator), CIRM (DR2-05373) (2011-2012)
- K08 Mentored Research Grant: PI, NIH-KNS085333A (2013-2018)
- Stanford Cancer Institute Bioscience Screening Award, Stanford Cancer Institute (2014)
- Stanford Spectrum-Medtech Translational Grant, Stanford Spectrum (2014)
Publications
-
Retrosigmoid Versus Translabyrinthine Approach for Acoustic Neuroma Resection: An Assessment of Complications and Payments in a Longitudinal Administrative Database.
Cole, T., Veeravagu, A., Zhang, M., Azad, T., Swinney, C., & Giannotta, S. L. Retrosigmoid Versus Translabyrinthine Approach for Acoustic Neuroma Resection: An Assessment of Complications and Payments in a Longitudinal Administrative Database. Cureus, 7(10), e369. -
Glioblastoma Multiforme Recurrence: An Exploratory Study of (18)F FPPRGD2 PET/CT.
Iagaru, A., Mosci, C., Mittra, E., Zaharchuk, G., Fischbein, N., & Gambhir, S. S. (2015). Glioblastoma Multiforme Recurrence: An Exploratory Study of (18)F FPPRGD2 PET/CT. Radiology, 277(2), 497-506. -
Repeat Courses of Stereotactic Radiosurgery (SRS), Deferring Whole-Brain Irradiation, for New Brain Metastases After Initial SRS
Shultz, D. B., Modlin, L. A., Jayachandran, P., von Eyben, R., Gibbs, I. C., & Soltys, S. G. (2015). Repeat Courses of Stereotactic Radiosurgery (SRS), Deferring Whole-Brain Irradiation, for New Brain Metastases After Initial SRS. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 92(5), 993-999. -
Casein kinase 2 alpha regulates glioblastoma brain tumor-initiating cell growth through the beta-catenin pathway
Nitta, R. T., Gholamin, S., Feroze, A. H., Agarwal, M., Cheshier, S. H., & Li, G. (2015). Casein kinase 2 alpha regulates glioblastoma brain tumor-initiating cell growth through the beta-catenin pathway. ONCOGENE, 34(28), 3688-3699.
-
Combining immunotherapy with radiation for the treatment of glioblastoma.
Chow, K. K., Hara, W., Lim, M., & Li, G. (2015). Combining immunotherapy with radiation for the treatment of glioblastoma. Journal of neuro-oncology, 123(3), 459-464.
-
Glioblastoma antigen discovery--foundations for immunotherapy.
Azad, T. D., Razavi, S.-M., Jin, B., Lee, K., & Li, G. (2015). Glioblastoma antigen discovery--foundations for immunotherapy. Journal of neuro-oncology, 123(3), 347-358.
-
Phase II pilot study of single-agent etirinotecan pegol (NKTR-102) in bevacizumab-resistant high grade glioma
Nagpal, S., Recht, C. K., Bertrand, S., Thomas, R. P., Ajlan, A., & Recht, L. D. (2015). Phase II pilot study of single-agent etirinotecan pegol (NKTR-102) in bevacizumab-resistant high grade glioma. JOURNAL OF NEURO-ONCOLOGY, 123(2), 277-282.
-
gamma-Glutamyl transferase 7 is a novel regulator of glioblastoma growth
Bui, T. T., Nitta, R. T., Kahn, S. A., Razavi, S.-M., Agarwal, M., & Li, G. (2015). gamma-Glutamyl transferase 7 is a novel regulator of glioblastoma growth. BMC CANCER, 15.
-
Preoperative endovascular embolization of meningiomas: update on therapeutic options
Shah, A., Choudhri, O., Jung, H., & Li, G. (2015). Preoperative endovascular embolization of meningiomas: update on therapeutic options. NEUROSURGICAL FOCUS, 38(3).
-
Dual-trajectory Approach for Simultaneous Cyst Fenestration and Endoscopic Third Ventriculostomy for Treatment of a Complex Third Ventricular Arachnoid Cyst.
Ho, A. L., Pendharkar, A. V., Sussman, E. S., Ravikumar, V. K., & Li, G. H. (2015). Dual-trajectory Approach for Simultaneous Cyst Fenestration and Endoscopic Third Ventriculostomy for Treatment of a Complex Third Ventricular Arachnoid Cyst. Cureus, 7(3).
-
The Combined Subtemporal-Transfacial Approach for the Resection of Juvenile Nasopharyngeal Angiofibromas With Intracranial Extension
Kumar, A. R., Nayak, J. V., Janisiewicz, A. M., Li, G., & Oghalai, J. S. (2015). The Combined Subtemporal-Transfacial Approach for the Resection of Juvenile Nasopharyngeal Angiofibromas With Intracranial Extension. OTOLOGY & NEUROTOLOGY, 36(1), 151-155.
-
Intracranial Dislocation of the Mandibular Condyle: A Case Report and Literature Review.
Zhang, M., Alexander, A., Most, S. P., Li, G., & Harris, O. A. (2015). Intracranial Dislocation of the Mandibular Condyle: A Case Report and Literature Review. World neurosurgery.
-
Craniotomy for Resection of Meningioma: An Age Stratified Analysis of the MarketScan Longitudinal Database.
Connolly, I. D., Cole, T., Veeravagu, A., Popat, R., Ratliff, J., & Li, G. (2015). Craniotomy for Resection of Meningioma: An Age Stratified Analysis of the MarketScan Longitudinal Database. World neurosurgery.
-
107 ReACT: Overall Survival From a Randomized Phase II Study of Rindopepimut (CDX-110) Plus Bevacizumab in Relapsed Glioblastoma.
Reardon, D. A., Schuster, J. M., Tran, D. D., Fink, K. L., Nabors, L. B., & Sampson, J. H. (2015). 107 ReACT: Overall Survival From a Randomized Phase II Study of Rindopepimut (CDX-110) Plus Bevacizumab in Relapsed Glioblastoma. Neurosurgery, 62 Suppl 1, CLINICAL NEUROSURGERY, 198-199.
-
Neurosurgery Concepts: Key perspectives on quality of life in children with spina bifida, cilengitide for the treatment of newly diagnosed glioblastoma, surgery and stereotactic radiosurgery in the management of intracranial metastasis, Gamma Knife radiosurgery in patients with Neurofibromatosis Type 2, patient misconceptions on the diagnosis and treatment of lumbar spondylosis.
Lam, S., Li, G., Zada, G., Pelargos, P., Choy, W., & Smith, Z. A. (2015). Neurosurgery Concepts: Key perspectives on quality of life in children with spina bifida, cilengitide for the treatment of newly diagnosed glioblastoma, surgery and stereotactic radiosurgery in the management of intracranial metastasis, Gamma Knife radiosurgery in patients with Neurofibromatosis Type 2, patient misconceptions on the diagnosis and treatment of lumbar spondylosis. Surgical neurology international, 6, 110.
-
Neurosurgery Concepts: Key perspectives on Traumatic Brain Injury, New Treatments for Glioblastoma, Hemicraniectomy for Extensive Middle-Cerebral-Artery Stroke, Minimally Invasive Spine Surgery and Lumbar Epidural Injections for Radiculopathy.
Cho, J. M., Colen, C. B., Li, G., Wang, V. Y., Dahdaleh, N., & Smith, Z. A. (2015). Neurosurgery Concepts: Key perspectives on Traumatic Brain Injury, New Treatments for Glioblastoma, Hemicraniectomy for Extensive Middle-Cerebral-Artery Stroke, Minimally Invasive Spine Surgery and Lumbar Epidural Injections for Radiculopathy. Surgical neurology international, 6, 98.
-
Neurosurgery concepts: Key perspectives on dendritic cell vaccines, metastatic tumor treatment, and radiosurgery.
Li, G., Sherman, J. H., Cho, J. M., Lim, M., Khalessi, A. A., & Yang, I. (2015). Neurosurgery concepts: Key perspectives on dendritic cell vaccines, metastatic tumor treatment, and radiosurgery. Surgical neurology international, 6, 6.
-
Intracranial fat migration: A newly described complication of autologous fat repair of a cerebrospinal fluid leak following supracerebellar infratentorial approach.
Ludwig, C. A., Aujla, P., Moreno, M., Veeravagu, A., & Li, G. (2015). Intracranial fat migration: A newly described complication of autologous fat repair of a cerebrospinal fluid leak following supracerebellar infratentorial approach. International journal of surgery case reports, 7C, 1-5.
-
Atypical and Rare Variants of Central Neurocytomas
Choudhri, O., Razavi, S.-M., Vogel, H., & Li, G. (2015). Atypical and Rare Variants of Central Neurocytomas. NEUROSURGERY CLINICS OF NORTH AMERICA, 26(1), 91-?.
-
Targeting a Glioblastoma Cancer Stem-Cell Population Defined by EGF Receptor Variant III
Emlet, D. R., Gupta, P., Holgado-Madruga, M., Del Vecchio, C. A., Mitra, S. S., & Wong, A. J. (2014). Targeting a Glioblastoma Cancer Stem-Cell Population Defined by EGF Receptor Variant III. CANCER RESEARCH, 74(4), 1238-1249.
-
Current Vaccine Trials in Glioblastoma: A Review
Xu, Lw., Chow, K. K., Lim, M., & Li, G. (2014). Current Vaccine Trials in Glioblastoma: A Review. JOURNAL OF IMMUNOLOGY RESEARCH.
-
Pilocytic astrocytoma with IDH1 mutation in the cerebellum of an elderly patient.
Medress, Z. A., Xu, L. W., Ziskin, J. L., Lefterova, M., Vogel, H., & Li, G. (2014). Pilocytic astrocytoma with IDH1 mutation in the cerebellum of an elderly patient. Clinical neuropathology.
-
The Future of Glioblastoma Therapy: Synergism of Standard of Care and Immunotherapy.
Patel, M. A., Kim, J. E., Ruzevick, J., Li, G., & Lim, M. (2014). The Future of Glioblastoma Therapy: Synergism of Standard of Care and Immunotherapy. Cancers, 6(4), 1953-1985.
-
Risk of Leptomeningeal Disease in Patients Treated With Stereotactic Radiosurgery Targeting the Postoperative Resection Cavity for Brain Metastases
Atalar, B., Modlin, L. A., Choi, C. Yh., Adler, J. R., Gibbs, I. C., & Soltys, S. G. (2013). Risk of Leptomeningeal Disease in Patients Treated With Stereotactic Radiosurgery Targeting the Postoperative Resection Cavity for Brain Metastases. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 87(4), 713-718.
-
Multi-institutional validation of a preoperative scoring system which predicts survival for patients with glioblastoma
Chaichana, K. L., Pendleton, C., Chambless, L., Camara-Quintana, J., Nathan, J. K., & Quinones-Hinojos, A. (2013). Multi-institutional validation of a preoperative scoring system which predicts survival for patients with glioblastoma. JOURNAL OF CLINICAL NEUROSCIENCE, 20(10), 1422-1426.
-
The invasive nature of glioblastoma.
Nitta, R. T., & Li, G. (2013). The invasive nature of glioblastoma. World neurosurgery, 80(3-4), 279-280.
-
The incidence and significance of multiple lesions in glioblastoma
Thomas, R. P., Xu, L. W., Lober, R. M., Li, G., & Nagpal, S. (2013). The incidence and significance of multiple lesions in glioblastoma. JOURNAL OF NEURO-ONCOLOGY, 112(1), 91-97.
-
Neurosurgery concepts: Key perspectives on regulatory proteins, management of ossification of the posterior longitudinal ligament, and radiosurgery for intracranial lesions.
Sherman, J. H., Smith, Z. A., Cho, J. M., Lim, M., Colen, C. B., & Yang, I. (2013). Neurosurgery concepts: Key perspectives on regulatory proteins, management of ossification of the posterior longitudinal ligament, and radiosurgery for intracranial lesions. Surgical neurology international, 4, 35-?.
-
Casein Kinase 2: a novel player in glioblastoma therapy and cancer stem cells.
Agarwal, M., Nitta, R. T., & Li, G. (2013). Casein Kinase 2: a novel player in glioblastoma therapy and cancer stem cells. Journal of molecular and genetic medicine : an international journal of biomedical research, 8(1).
-
The predictive value of serum myeloperoxidase for vasospasm in patients with aneurysmal subarachnoid hemorrhage
Lim, M., Bower, R. S., Wang, Y., Sims, L., Bower, M. R., & Guccione, S. (2012). The predictive value of serum myeloperoxidase for vasospasm in patients with aneurysmal subarachnoid hemorrhage. NEUROSURGICAL REVIEW, 35(3), 413-419.
-
Expression of epidermal growth factor variant III (EGFRvIII) in pediatric diffuse intrinsic pontine gliomas
Li, G., Mitra, S. S., Monje, M., Henrich, K. N., Bangs, C. D., & Wong, A. J. (2012). Expression of epidermal growth factor variant III (EGFRvIII) in pediatric diffuse intrinsic pontine gliomas. JOURNAL OF NEURO-ONCOLOGY, 108(3), 395-402.
-
Arachnoid ossificans containing metaplastic hematopoietic marrow resulting in diffuse thoracic intrathecal cysts and severe myelopathy.
Abrams, J., Li, G., Mindea, S. A., Haynes, C. M., & Cheng, I. (2012). Arachnoid ossificans containing metaplastic hematopoietic marrow resulting in diffuse thoracic intrathecal cysts and severe myelopathy. European spine journal , 21, S436-40.
-
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
Willingham, S. B., Volkmer, J.-P., Gentles, A. J., Sahoo, D., Dalerba, P., & Weissman, I. L. (2012). The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 109(17), 6662-6667.
-
Pathology: Commonly Monitored Glioblastoma Markers: EFGR, EGFRvIII, PTEN, and MGMT
Camara-Quintana, J. Q., Nitta, R. T., & Li, G. (2012). Pathology: Commonly Monitored Glioblastoma Markers: EFGR, EGFRvIII, PTEN, and MGMT. NEUROSURGERY CLINICS OF NORTH AMERICA, 23(2), 237-?.
-
Targeting EGF receptor variant III: tumor-specific peptide vaccination for malignant gliomas
Del Vecchio, C. A., Li, G., & Wong, A. J. (2012). Targeting EGF receptor variant III: tumor-specific peptide vaccination for malignant gliomas. EXPERT REVIEW OF VACCINES, 11(2), 133-144.
-
Perspectives on key articles in neurosurgery.
Lim, M., Sherman, J. H., Wang, V. Y., Smith, Z. A., Cho, J. M., & Yang, I. (2012). Perspectives on key articles in neurosurgery. Surgical neurology international, 3, 58-?.
-
RADIOSURGERY OF GLOMUS JUGULARE TUMORS: A META-ANALYSIS
Guss, Z. D., Batra, S., Limb, C. J., Li, G., Sughrue, M. E., & Lim, M. (2011). RADIOSURGERY OF GLOMUS JUGULARE TUMORS: A META-ANALYSIS. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 81(4), E497-E502.
-
Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma
Monje, M., Mitra, S. S., Freret, M. E., Raveh, T. B., Kim, J., & Beachy, P. A. (2011). Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 108(11), 4453-4458.
-
Neurosurgery concepts.
Yang, I., Cho, J. M., Colen, C. B., Li, G., Lim, M., & Wang, V. Y. (2011). Neurosurgery concepts. Surgical neurology international, 2, 173-?.
-
Development of an EGFRvIII specific recombinant antibody
Gupta, P., Han, S.-Y., Holgado-Madruga, M., Mitra, S. S., Li, G., & Wong, A. J. (2010). Development of an EGFRvIII specific recombinant antibody. BMC BIOTECHNOLOGY, 10.
-
Pineal Parenchymal Tumor of Intermediate Differentiation: Clinicopathological Report and Analysis of Epidermal Growth Factor Receptor Variant III Expression
Li, G., Mitra, S., Karamchandani, J., Edwards, M. Sb., & Wong, A. J. (2010). Pineal Parenchymal Tumor of Intermediate Differentiation: Clinicopathological Report and Analysis of Epidermal Growth Factor Receptor Variant III Expression. NEUROSURGERY, 66(5), 963-968.
-
Passive Antibody-Mediated Immunotherapy for the Treatment of Malignant Gliomas
Mitra, S., Li, G., & Harsh, G. R. (2010). Passive Antibody-Mediated Immunotherapy for the Treatment of Malignant Gliomas. NEUROSURGERY CLINICS OF NORTH AMERICA, 21(1), 67-?.
-
The Epidermal Growth Factor Variant III Peptide Vaccine for Treatment of Malignant Gliomas
Li, G., Mitra, S., & Wong, A. J. (2010). The Epidermal Growth Factor Variant III Peptide Vaccine for Treatment of Malignant Gliomas. NEUROSURGERY CLINICS OF NORTH AMERICA, 21(1), 87-?.
-
Radiosurgery for glomus jugulare: history and recent progress
Guss, Z. D., Batra, S., Li, G., Chang, S. D., Parsa, A. T., & Lim, M. (2009). Radiosurgery for glomus jugulare: history and recent progress. NEUROSURGICAL FOCUS, 27(6).
-
CYBERKNIFE FOR BRAIN METASTASES OF MALIGNANT MELANOMA AND RENAL CELL CARCINOMA
Hara, W., Tran, P., Li, G., Su, Z., Puataweepong, P., & Gibbs, I. C. (2009). CYBERKNIFE FOR BRAIN METASTASES OF MALIGNANT MELANOMA AND RENAL CELL CARCINOMA. NEUROSURGERY, 64(2), A26-A32.
-
Perioperative management of ventriculoperitoneal shunts during abdominal surgery
Li, G., & Dutta, S. (2008). Perioperative management of ventriculoperitoneal shunts during abdominal surgery. SURGICAL NEUROLOGY, 70(5), 492-497.
-
EGF receptor variant III as a target antigen for tumor immunotherapy
Li, G., & Wong, A. J. (2008). EGF receptor variant III as a target antigen for tumor immunotherapy. EXPERT REVIEW OF VACCINES, 7(7), 977-985.
-
Effects of age and Comorbidities on complication rates and adverse outcomes after lumbar laminectomy in elderly patients
Li, G., Patil, C. G., Lad, S. P., Ho, C., Tian, W., & Boakye, M. (2008). Effects of age and Comorbidities on complication rates and adverse outcomes after lumbar laminectomy in elderly patients. SPINE, 33(11), 1250-1255.
-
Intracranial hypotension from intrathecal baclofen pump insertion
Lad, S. P., Li, G., Lin, S.-C., & Henderson, J. M. (2008). Intracranial hypotension from intrathecal baclofen pump insertion. STEREOTACTIC AND FUNCTIONAL NEUROSURGERY, 86(2), 75-79.
-
CyberKnife radiosurgical rhizotomy for the treatment of atypical trigeminal nerve pain.
Patil, C. G., Veeravagu, A., Bower, R. S., Li, G., Chang, S. D., & Adler, J. R. (2007). CyberKnife radiosurgical rhizotomy for the treatment of atypical trigeminal nerve pain. Neurosurgical focus, 23(6), E9-?.
-
Irradiation of glomus jugulare tumors: a historical perspective.
Li, G., Chang, S., Adler, J. R., & Lim, M. (2007). Irradiation of glomus jugulare tumors: a historical perspective. Neurosurgical focus, 23(6), E13-?.
-
CyberKnife rhizotomy for facetogenic back pain: a pilot study.
Li, G., Patil, C., Adler, J. R., Lad, S. P., Soltys, S. G., & Boakye, M. (2007). CyberKnife rhizotomy for facetogenic back pain: a pilot study. Neurosurgical focus, 23(6), E2-?.
-
Carotid and vertebral rete mirabile in man presenting with intraparenchymal hemorrhage: a case report.
Li, G., Jayaraman, M. V., Lad, S. P., Adler, J., Do, H., & Steinberg, G. K. (2006). Carotid and vertebral rete mirabile in man presenting with intraparenchymal hemorrhage: a case report. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 15(5), 228-231.
-
Cerebral perfusion imaging in vasospasm.
Lad, S. P., Guzman, R., Kelly, M. E., Li, G., Lim, M., & Steinberg, G. K. (2006). Cerebral perfusion imaging in vasospasm. Neurosurgical focus, 21(3), E7-?.
-
Surfactant protein-A-deficient mice display an exaggerated early inflammatory response to a beta-resistant strain of influenza A virus
Li, G., Siddiqui, J., Hendry, M., Akiyama, J., Edmondson, J., & Hawgood, S. (2002). Surfactant protein-A-deficient mice display an exaggerated early inflammatory response to a beta-resistant strain of influenza A virus. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 26(3), 277-282.
-
GM-CSF mediates alveolar macrophage proliferation and type II cell hypertrophy in SP-D gene-targeted mice
Hawgood, S., Akiyama, J., Brown, C., Allen, L., Li, G., & Poulain, F. R. (2001). GM-CSF mediates alveolar macrophage proliferation and type II cell hypertrophy in SP-D gene-targeted mice. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 280(6), L1148-L1156.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Patient Comments
Patients comments are gathered from our Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
SHC Patient, Jul 2015
Dr. Li is excellent. He emails me directly to ask for my progress, and replies quickly. So problems can be quickly addressed.
SHC Patient, Jun 2015
The clinic sets the best example for their patience.
SHC Patient, Feb 2015
Dr. Gordon Li delivers the highest level of excellence in care with compassion, yet he is humble and approachable. I highly appreciate his care.
SHC Patient, Jan 2015
Good experience.
SHC Patient, Jan 2015
Was the 1st visit we were ever confident in provider or facility.
SHC Patient, Nov 2014
Dr. Li is VERY GOOD.
SHC Patient, Oct 2014
I would have liked a little more discussion about my condition, but understood that since I wasn't a surgical candidate, a referral to another dr. was approp.
SHC Patient, Aug 2014
Dr. Gordon Li is outstanding! I love him! He is kind, attentive, knowledgeable, compassionate and so very capable! I and Stanford are so fortunate to have him as a dr. I wish all doctors were as awesome as he is!!
SHC Patient, Jun 2014
Dr. Li was excellent, great bed side manner & actually listened to my concerns.
SHC Patient, Feb 2014
If my condition takes a turn for the worse - I'll be back!
SHC Patient, Feb 2014
All very good.
SHC Patient, Dec 2013
Was never alone in exam room.
SHC Patient, Jul 2015
Dr. Li is excellent. He emails me directly to ask for my progress, and replies quickly. So problems can be quickly addressed.
SHC Patient, Jun 2015
The clinic sets the best example for their patience.
SHC Patient, Feb 2015
Dr. Gordon Li delivers the highest level of excellence in care with compassion, yet he is humble and approachable. I highly appreciate his care.
SHC Patient, Jan 2015
Good experience.
SHC Patient, Jan 2015
Was the 1st visit we were ever confident in provider or facility.
SHC Patient, Nov 2014
Dr. Li is VERY GOOD.
SHC Patient, Oct 2014
I would have liked a little more discussion about my condition, but understood that since I wasn't a surgical candidate, a referral to another dr. was approp.
SHC Patient, Aug 2014
Dr. Gordon Li is outstanding! I love him! He is kind, attentive, knowledgeable, compassionate and so very capable! I and Stanford are so fortunate to have him as a dr. I wish all doctors were as awesome as he is!!
SHC Patient, Jun 2014
Dr. Li was excellent, great bed side manner & actually listened to my concerns.
SHC Patient, Feb 2014
If my condition takes a turn for the worse - I'll be back!
SHC Patient, Feb 2014
All very good.
SHC Patient, Dec 2013
Was never alone in exam room.